Last $3.74 USD
Change Today -0.04 / -1.06%
Volume 35.5K
CEMI On Other Exchanges
As of 8:10 PM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

chembio diagnostics inc (CEMI) Snapshot

Previous Close
Day High
Day Low
52 Week High
10/27/14 - $5.20
52 Week Low
05/8/14 - $2.83
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

chembio diagnostics inc (CEMI) Related Businessweek News

No Related Businessweek News Found

chembio diagnostics inc (CEMI) Details

Chembio Diagnostics, Inc., together with its wholly-owned subsidiary, Chembio Diagnostic Systems, Inc., develops, manufactures, markets, and licenses rapid point-of-care diagnostic tests that detect infectious diseases. It offers rapid tests for the detection of HIV and syphilis antibodies. The company’s products include lateral flow rapid HIV tests and Dual Path Platform (DPP) HIV Test, which detect antibodies to HIV 1 and 2 with visually interpreted results; a Syphilis multiplex test for the detection of antibodies to HIV and Syphilis; and a rapid test for the detection of Hepatitis-C antibodies and antigens. Chembio Diagnostics, Inc. sells its products under STAT PAK, SURE CHECK, or DPP trademarks, as well as under the private labels of its marketing partners to medical laboratories and hospitals, governmental and public health entities, non-governmental organizations, medical professionals, and retail establishments in the United States and internationally. The company has collaboration agreements with the Oswaldo Cruz Foundation relating to products based on its DPP technology products. Chembio Diagnostics, Inc. was founded in 1985 and is headquartered in Medford, New York.

206 Employees
Last Reported Date: 03/6/14
Founded in 1985

chembio diagnostics inc (CEMI) Top Compensated Officers

Chief Operating Officer
Total Annual Compensation: $239.6K
Senior Vice President of Research & Developme...
Total Annual Compensation: $337.1K
Compensation as of Fiscal Year 2013.

chembio diagnostics inc (CEMI) Key Developments

Chembio Diagnostics Systems, Inc. Appoints Paul Lambotte as Vice President, Product Development

Chembio Diagnostics Systems, Inc. announced the appointment of Paul Lambotte, Ph.D., as Vice President, Product Development. In this newly created position, Dr. Lambotte joins Chembio's Executive Leadership Team reporting to Sharon Klugewicz, Chief Operating Officer, and has responsibility for leading Chembio's internally-funded Product Development programs. Javan Esfandiari, Chembio's Chief Science & Technology Officer, continues to lead Chembio's externally-funded Research programs, reporting to John Sperzel, Chief Executive Officer.

Chembio Diagnostics, Inc. Enters into an Agreement with the Concussion Science Group

Chembio Diagnostics, Inc. announced that it has entered into an agreement with the Concussion Science Group (CSG) Division of Perseus Science Group LLC, to utilize Chembio's patented DPP® technology to develop a POC diagnostic test for traumatic brain injury (TBI), including sports-related concussion. Under terms of the agreement, CSG's patented biomarker will be combined with Chembio's proprietary DPP® platform to develop a semi-quantitative or quantitative point-of-care test to diagnose TBI. CSG has agreed to pay Chembio milestone development payments during 2015.

Chembio Diagnostics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 02:00 PM

Chembio Diagnostics, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-13-2015 02:00 PM. Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States. Speakers: John J. Sperzel, Chief Executive Officer, President and Director.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CEMI:US $3.74 USD -0.04

CEMI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Alere Inc $40.69 USD +0.12
OraSure Technologies Inc $9.19 USD -0.58
Trinity Biotech PLC $18.54 USD -0.25
View Industry Companies

Industry Analysis


Industry Average

Valuation CEMI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.3x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.1x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CHEMBIO DIAGNOSTICS INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at